Bluegrass Vascular Technologies said it named Gabriele Niederauer its new president & CEO, hard on the heels of a Series A funding round that brought in $4.5 million for its Surfacer central venous catheter.
LED Medical Diagnostics Inc.
Medtech personnel moves for the week of Mar. 17, 2014
IsoRay mourns death of vice-chair Robert Kauffman | Personnel Moves
Radiation therapy devices maker IsoRay (AMEX:ISR) announced the sudden death of company vice-chairman Robert Kauffman, who passed away on March 7.
Kauffman had been with the company since 2005 and was named vice-chairman in 2008. IsoRay is looking to fill the hole he left behind, but there are no immediate nominations or arrangements, according to an IsoRay regulatory filing.
Conventus takes new execs from high-target rivals | Personnel Moves
Minnesota medical device maker Conventus Orthopaedics is swapping some executives, naming a new chief executive officer and new chief commercial officer in one fell swoop.
The orthopedics company appointed as its new CEO Paul Buckman, who brought with him years of medtech experience at companies including Boston Scientific and St. Jude Medical. Buckman also co-founded ev3, which Covidien acquired in 2010 for $2.6 billion. Buckman has also served on Conventus’ board of directors since 2009.
World Heart’s 2011 sales go negative | Earnings roundup
Ortho stocks up on strong Q2 prelims for Biomet | Earnings Roundup
Shares of orthopedic device makers are up this morning after bellwether Biomet Inc. reported preliminary sales numbers indicating 3.8% growth for its fiscal second quarter.
Symmetry Medical bags J&J surgical instruments arm for $165M | Acquisitions Roundup
Orthopedic company Symmetry Medical (NYSE:SMA) signed a definitive agreement to acquire the surgical instrument business of Johnson & Johnson (NYSE:JNJ) subsidiary Codman & Shurtleff for $165 million cash.
Symmetry plans to integrate its current hospital direct business, Specialty Surgical Instrumentation, with Codman’s line of surgical instruments.
Acquisition chatter surfaces again for Smith & Nephew
Shares of Smith & Nephew (NYSE:SNN) slipped initially but have regained some of their value since more talk of a possible buyout surfaced in the U.K. last week.
The British orthopedics giant is up 2.7 percent on The Street today to $43.94 after flirting with a 52-week low Friday, Nov. 25. The stock has fared even worse in its home country following an "uninspiring" meeting with analysts last week.
Contact lenses with real-time info display | MassDevice.com On Call
MASSDEVICE ON CALL — Researchers unveiled the first prototype of a contact lens capable of displaying information updates that the wearer can see.
The concept device only displayed one pixel, but has applications in gaming, navigation and even health readings, according to researchers at the University of Washington in conjunction with Aalto University Finland.